neobookRx

Diabetic Ketoacidosis

Diabetic Ketoacidosis

Description

Diagnostic criteria

General and supportive measures

Medicine treatment

Referral


ICD-10 Code: E10.1

DESCRIPTION

Diabetic ketoacidosis (DKA) occurs with relative or absolute insulin deficiency, either caused by non-adherence to insulin regimens or by excessive secretion of counter-regulatory hormones during stress, e.g. infection, trauma and surgery.

DIAGNOSTIC CRITERIA

  • Heavy glycosuria (3+ or more).
  • Hyperglycaemia, i.e. blood glucose usually > 11 mmol/L, ketonuria 2+.
  • Blood gas: pH < 7.3, bicarbonate < 15 mmol/L.
  • Polyuria, polydipsia and dehydration.
  • Kussmaul respiration, nausea, vomiting, abdominal pain and depressed level of consciousness are all late signs.

Note: In rare cases, blood glucose is not elevated.
Children with mild dehydration and not clinically unwell usually tolerate oral rehydration and subcutaneous insulin.

See: Guidelines for management of diabetics on sick days.


GENERAL AND SUPPORTIVE MEASURES

  • Admit all children and adolescents to an ICU or ward experienced in the management of DKA in children and adolescents, if possible.
  • Ensure patent airway.
  • If the child is comatosed, secure the airway and insert a urinary catheter.
  • If comatosed or has recurrent vomiting insert an oro-/nasogastric tube and apply free drainage.

MEDICINE TREATMENT

Seek specialist advice early in the management.

If hypoxaemic:

  • Oxygen via facemask.

The objectives of fluid and sodium replacement therapy in diabetic ketoacidosis are:

  • To restore circulating volume.
  • To replace sodium and water deficits from extracellular and intracellular compartments.
  • To restore glomerular filtration rate to enhance clearance of glucose and ketones from the blood.
  • To reduce the risk of cerebral oedema.

Fluids
a: Fluids for resuscitation in shock:

  • Sodium chloride 0.9%, IV, 10–20 mL/kg over 10–30 minutes.
    • Repeat if shock persists.

b: Fluid requirements after resuscitation
Maintenance (over 24 hrs) 

≤ 10 kg 100 ml/kg/24 hrs
11–20 kg

1000 ml + 50 ml/kg/24 hrs for each kg from 11–

20 kg

> 20 kg 1500 ml + 20 ml/kg/24 hrs for each kg > 20 kg

Obese children: Use ideal body weight for height.
+
Rehydration (over 48 hours) 

5% dehydrated 50 ml/kg/48 hrs
10% dehydrated 100 ml/kg/48 hrs

Review at least 2 hourly.
+/-
Ongoing losses 

Replace urine loss in excess of
2 ml/kg/hour
= urine output (in ml/kg/hr) -
2 ml/kg/hr

Review at least 2 hourly.

Examples of fluid volumes for subsequent phase of rehydration (i.e. maintenance + 5% of body weight/24 hours)

Body weight (kg)

Maintenance 

(mL/24 hour)

Maintenance + 5%  of body weight 

(mL/24 hrs)

Maintenance + 5%  of body weight 

(mL/hour)

4 

325 

530 

22

5 

405 

650 

27

6 

485 

790 

33

7 

570 

920 

38

8 

640 

1040 

43

9 

710 

1160 

48

10 

780 

1280 

53

11 

840 

1390 

58

12 

890 

1490 

62

13 

940 

1590 

66

14 

990 

1690 

70

15 

1030 

1780 

74

16 

1070 

1870 

78

17 

1120 

1970 

82

18 

1150 

2050 

85

19 

1190 

2140 

89

20 

1230 

2230 

93

22 

1300 

2400 

100

24 

1360 

2560 

107

26 

1430 

2730 

114

28 

1490 

2890 

120

30 

1560 

3060 

128

32 

1620 

3220 

134

34 

1680 

3360 

140

36 

1730 

3460 

144

38 

1790 

3580 

149

40 

1850 

3700 

154

45 

1980 

3960 

165

50 

2100 

4200 

175

55 

2210 

4420 

184

60 

2320 

4640 

193

65 

2410 

4820 

201

70 

2500 

5000 

208

75 

2590 

5180 

216

80 

2690 

5380 

224


Note:  Sodium chloride 0.9% is preferred for resuscitation and the initial phase of rehydration.  However, to prevent the occurrence of hyperchloraemic acidosis switch to sodium chloride 0.45%/dextrose 5% after blood glucose has fallen to 12 mmol/L or less. Monitor sodium and chloride (on VBG) 4–6 hourly and adjust maintenance fluids as necessary.


Note: One of the danger signals for cerebral oedema is a precipitous drop in the serum sodium level.


Bicarbonate

Bicarbonate use is associated with increased risk of cerebral oedema. It should not be used routinely to improve adicosis.


Caution:
Consult a specialist before administering any bicarbonate solution.


Potassium

Commence potassium replacement immediately unless patient has anuria. If serum potassium is high, start replacement after the patient has passed urine.
Early addition of potassium in the fluid regimen (KCl 15% 20mL in 1L = 40 mmol/L) is essential even if the serum concentration is normal as insulin will drive glucose and potassium into the cells.

DKA protocol:
Two-bag system – Alternative fluid and electrolyte treatment

Under supervision of a specialist.
The two-bag system consists of 2 bags of identical electrolyte content but different dextrose concentrations, 0% and 10%, administered simultaneously into a single IV line. Variations in dextrose delivery are achieved through changing the proportions of the 2 bags contributing to the total rate, which is determined by the degree of dehydration.

  • Sodium chloride 0.9%, IV, 10–20 mL/kg.
    • May be repeated if necessary.
    • Then switch to the two-bag system.
Bag 1
(dextrose 0%)
Bag 2
(dextrose 10%)
Sodium chloride 0.45%, 1 L
PLUS
Potassium chloride, 20 mL
Dextrose 10%, 1 L
PLUS
Sodium chloride 5%, 90 mL
PLUS
Potassium chloride, 20 mL

Run these two riders for easy titration of dextrose from dextrose 10% to dextrose 0%: 

Fluid Blood glucose
> 15 mmol/L
Blood glucose
10–15 mmol/L
Blood glucose
< 10 mmol/L
Bag 1  100% 50% 0%
Bag 2  0% 50% 100%

LoE II 2,3

Insulin

  • Insulin, short acting, 0.05-0.1 units/kg/hour as a continuous IV infusion.
    • Add insulin, 50 units (0.5 mL) to 50 mL sodium chloride 0.9% in a syringe pump to get a solution of 1 unit/mL.
    • Use a separate cannula and line for insulin administration.
    • Do not add insulin directly to the fluid bags administering maintenance and rehydration fluids.  

      If the rate of blood glucose fall exceeds 5 mmol/ L/hour or the blood glucose falls to 17 mmol/L:
    • Add a dextrose-containing fluid.
    • Do not stop the insulin infusion while dextrose is being infused. 

      If the blood glucose falls below 5 mmol/L:
    • Give a bolus of 2 mL/kg of dextrose 10% and increase the concentration of dextrose in the infusion.

      Continue with IV insulin until:
    • base deficit is < 5 or bicarbonate is ≥ 15 mmol/L,
    • there is no ketonuria, and
    • blood glucose is ≤ 10 mmol/L.

Alternative to insulin infusion

Where there are no facilities for insulin infusion, e.g. no syringe pumps, staff constraints, etc.:

  • Insulin short-acting, IV, 0.1 unit/kg, hourly.

Changing from intravenous to subcutaneous insulin

Continue with intravenous fluids until the child is drinking well and able to tolerate snacks. When oral fluids are tolerated, reduce intravenous fluids. Subcutaneous insulin can be started once the child is well hydrated and able to tolerate a normal diet.

The most convenient time to change to subcutaneous insulin is just before a meal. Administer the first dose of subcutaneous insulin 30 minutes before the meal and continue with the insulin infusion for 90 minutes after the subcutaneous injection to prevent rebound hyperglycaemia.

In newly diagnosed diabetics, basal-bolus regimen is started as described in Type 1 Diabetes Mellitus – Insulin Regimens, in a low range dose:

  • Prepubertal children: 0.7 units/kg.
  • Pubertal children: 1 unit/kg.

In established diabetics, give maintenance insulin.
Give supplemental subcutaneous short-acting insulin before meals if the blood glucose > 11 mmol/L: 

Blood glucose
(mmol/L)
Short-acting insulin
(units/kg/dose)
11-12 0.06
13-16 0.09
16 0.12

REFERRAL

  • No improvement.
  • Deterioration of condition, i.e.:
    • pH <7.1,
    • hyperventilation,
    • shock,
    • depressed level of consciousness,
    • persistent vomiting,
    • age < 5 years.
  • Rising blood glucose. 

Standard Treatment Guidelines and Essential Medicines List for South Africa, Hospital Level, Paediatrics,  2023 Edition

Chapter 7: Endocrine, 7.5 Diabetes Mellitus,  7.5.2 Diabetes Mellitus, Insulin Dependent: Acute Complications,  7.5.2.2 Diabetic Ketoacidosis

 

Drugs mentioned

ICD-10 codes

NeoHealth® ID 17110 · updated 5/16/2023